Post-bronchodilator values for FEV1 and FVC were analyzed for subjects completing at least the 1 year visit ( Placebo - N = 2463 ; Tiotropium - N = 2579 ) , stratified by GOLD stage , age , gender and smoking status and expressed as absolute , relative ( % ) and % predicted changes from pre-bronchodilator values .